Status:
COMPLETED
Pilocarpine Microneedles for Sweat Induction (PMN-SI)
Lead Sponsor:
Emory University
Collaborating Sponsors:
Georgia Institute of Technology
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators want to test in this non-randomized clinical trial a new method of administrating Pilocarpine medicine into the skin during the Sweat testing process that does not use any electrical...
Detailed Description
Sweat collection tests are done when a patient is suspected of having cystic fibrosis. This procedure for collection of sweat samples is called the Sweat Test and the measurement of sweat chloride con...
Eligibility Criteria
Inclusion
- Age \>18 years
- Signed a written informed consent
- Not taking any medications
- No known medical diagnoses or chronic conditions
Exclusion
- Age \<18 years
- Family history of Cystic Fibrosis
- History of skin disorders (eczema, psoriasis etc.) that could prevent sweat testing on forearms
- Current medication use
Key Trial Info
Start Date :
January 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04732195
Start Date
January 20 2022
End Date
March 17 2022
Last Update
May 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta - Egleston Hospital
Atlanta, Georgia, United States, 30322